Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Pathologic and imaging correlates of cognitive deficits in multiple sclerosis: changing the paradigm of diagnosis and prognosis.
Myelitis and optic neuritis induced by a long course of etanercept in a patient with rheumatoid arthritis.
EBV and vitamin D status in relapsing-remitting multiple sclerosis patients with a unique cytokine signature.
Relapsing Remitting Multiple Sclerosis Patients Initiated on Oral Dmf Report A Better Quality of Life Compared to Patients on Platform Therapies As Measured By Eq-5d.
Expression profiling of the ubiquitin conjugating enzyme UbcM2 in murine brain reveals modest age-dependent decreases in specific neurons.
Is the Iranian Revolution to Blame for the Increasing Incidence of Multiple Sclerosis in Iran?.
Occurrence of CCSVI in patients with MS and its relationship with iron metabolism and varicose veins.
Endotoxin- and ATP-neutralizing activity of alkaline phosphatase as a strategy to limit neuroinflammation.
Difficulties in Planning Among Patients with Multiple Sclerosis: A Relative Consequence of Deficits in Information Processing Speed.
Promising New Approaches to Assess Cognitive Functioning in People with Multiple Sclerosis.
Employment status in multiple sclerosis: impact of disease-specific and non-disease-specific factors.
[Assessment of the high cost drug program on an example of the interferon treatment of multiple sclerosis.]
MRI and magnetic resonance angiography findings in patients with multiple sclerosis mimicked by stroke.
Ghrelin inhibits oligodendrocyte cell death by attenuating microglial activation.
Self-esteem is associated with perceived stress in multiple sclerosis patients.
Cortical relapses in multiple sclerosis.
Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO.
Longitudinal MR Imaging of Iron in Multiple Sclerosis: An Imaging Marker of Disease.
Daclizumab, an IL-2 modulating antibody for treatment of multiple sclerosis.
Therapeutic Plasma Exchange in Glucocorticosteroid-Unresponsive Patients With Clinically Isolated Syndrome.
Sex drive and sexual desire.
Recurrent Guillain-Barré syndrome presenting stereotypic manifestations, positive antiganglioside antibodies, and rapid recovery.
Care Partners and Multiple Sclerosis: Differential Effect on Men and Women.
Soluble Tumor Necrosis Factor Receptor 1 Released by Skin-Derived Mesenchymal Stem Cells Is Critical for Inhibiting Th17 Cell Differentiation.
Mobility disability and the pattern of accelerometer-derived sedentary and physical activity behaviors in people with multiple sclerosis.
Pages
« first
‹ previous
…
568
569
570
571
572
573
574
575
576
…
next ›
last »